BridgeBio Pharma, Inc.

BBIO · Healthcare · BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases

BridgeBio Pharma, Inc. (BBIO), in the Healthcare sector, has 41 disclosed filings on Paydirt over the trailing twelve months from 1 member of Congress and 10 corporate insiders: 4 purchases and 37 sales. Filers took a median of 3 days from execution to disclosure, and the most recent trade was executed Sep 17 and filed Sep 21. The most active filer was Neil Kumar with 25 filings.

Add to watchlist

Filings, ttm

4 buys · 37 sells

Traders, ttm

1 congress · 10 insiders

Volume, ttmiDollar value disclosed in the window

$121.9M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Sep 17

Filed yesterday

ADViAverage daily dollar volume

$293.8M

market data

Share price · 12M

$79.37 (+54.0%)

Adjusted for splits and dividends.

Volume by month

Buys $56K Sells $867.6M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Neil Kumar Chief Executive Officer 25 filings HV

Hannah Valantine Director 6 filings GC

Gilbert Cisneros Representative 5 filings AE

Andrea Ellis Director 5 filings TT

Thomas Trimarchi President and CFO 5 filings MA

Maricel Apuli Chief Accounting Officer 4 filings FM

Frank McCormick Director 4 filings JC

Jennifer E. Cook Director 3 filings

Recent filings

Neil KumarSALE Chief Executive Officer $602K
8,721 sh × $69.01
Exec Sep 17
Filed Sep 21 · 6:21 PM ET Neil KumarSALE Chief Executive Officer $3.7M
44,880 sh across 6 lots
Exec Aug 18
Filed Aug 20 · 4:31 PM ET Maricel ApuliSALE Chief Accounting Officer $160K
2,000 sh × $80.06
Exec Jul 30
Filed Aug 3 · 4:20 PM ET Andrea EllisSALE Director $1.4M
17,167 sh × $84.00
Exec Jul 9
Filed Jul 13 · 4:41 PM ET Jennifer E. CookSALE Director $13.2M
148,589 sh across 2 lots
Exec Jul 9
Filed Jul 13 · 4:40 PM ET Hannah ValantineSALE Director $342K
5,004 sh across 2 lots
Exec Jun 22
Filed Jun 24 · 5:30 PM ET Jennifer E. CookSALE Director $2.8M
39,363 sh across 2 lots
Exec Jun 23
Filed Jun 24 · 5:30 PM ET Jennifer E. CookSALE Director $6.0M
90,240 sh across 2 lots
Exec Jun 15
Filed Jun 17 · 5:30 PM ET Neil KumarSALE Chief Executive Officer $5.2M
76,242 sh across 10 lots
Exec Jun 4
Filed Jun 8 · 5:30 PM ET Gilbert CisnerosPURCHASE Representative $8K
$1K–15K bracket
Exec May 11
Filed Jun 8 Neil KumarSALE Chief Executive Officer $1.8M
25,303 sh across 4 lots
Exec May 21
Filed May 26 · 5:30 PM ET Randal W. ScottSALE Director $658K
9,800 sh across 3 lots
Exec May 15
Filed May 19 · 5:30 PM ET Thomas TrimarchiSALE President and CFO $888K
13,651 sh across 2 lots
Exec May 18
Filed May 19 · 5:30 PM ET Neil KumarSALE Chief Executive Officer $5.2M
77,201 sh across 8 lots
Exec May 7
Filed May 11 · 5:30 PM ET Gilbert CisnerosPURCHASE Representative $8K
$1K–15K bracket
Exec Apr 29
Filed May 8 Maricel ApuliSALE Chief Accounting Officer $143K
2,000 sh × $71.58
Exec Apr 30
Filed May 4 · 5:30 PM ET Neil KumarSALE Chief Executive Officer $6.0M
80,000 sh across 8 lots
Exec Apr 9
Filed Apr 13 · 5:30 PM ET Gilbert CisnerosPURCHASE Representative $24K
3 lots · $3K–45K bracket
Exec Mar 3
Filed Apr 7 Neil KumarSALE Chief Executive Officer $5.5M
79,400 sh across 8 lots
Exec Mar 12
Filed Mar 16 · 5:30 PM ET Hannah ValantineSALE Director $624K
8,671 sh × $72.00
Exec Mar 10
Filed Mar 12 · 5:30 PM ET Andrea EllisSALE Director $4.2M
64,921 sh × $64.87
Exec Mar 4
Filed Mar 6 · 5:30 PM ET Hannah ValantineSALE Director $1.7M
25,484 sh across 2 lots
Exec Feb 27
Filed Mar 3 · 5:30 PM ET Maricel ApuliSALE Chief Accounting Officer $132K
2,000 sh × $66.00
Exec Feb 26
Filed Feb 27 · 5:30 PM ET Neil KumarSALE Chief Executive Officer $2.0M
27,451 sh across 2 lots
Exec Feb 19
Filed Feb 23 · 5:30 PM ET Randal W. ScottSALE Director $755K
10,000 sh across 3 lots
Exec Feb 17
Filed Feb 18 · 5:30 PM ET